2020 Virtual AIChE Annual Meeting

Session: Control Strategies in Pharmaceutical Drug Substance and Biologics Development and Manufacturing

Chair

Marton, C., Bristol Myers Squibb

Co-Chairs

Hannon, J., DynoChem Inc
Seibert, K., Eli Lilly

Presentations

08:00 AM

(367a) Leveraging of Modeling and Automation in Development of a Control Strategy for a cGMP Buchwald-Hartwig Cross-Coupling
Reizman, B., Kerr, M. S., Pietz, M. A., Jarmer, D. J.

08:15 AM

(367c) Moving to a Chromatography-Free Synthesis: Establishing Product-Related and Polymeric Impurity Control Strategy during Process Development
Purdum, G., Yuan, C., Zhu, G., Cohen, B. M., Yu, M., Wang, Q., Rogers, A.

08:30 AM

(367d) Process Control Strategy Development for an Integrated Continuous Platform for Monoclonal Antibody Manufacturing
Maloney, A. J., Bozinovski, D., Lu, A. E., Sangerman, J., Hong, M. S., Artamonova, A., Wen Ou, R., Sun, W., Wolfrum, J., Barone, P. W., Springs, S., Sinskey, A. J., Cummings Bende, E. M., Persits, N., Ram, R. J., Braatz, R.

08:45 AM

(367e) Modulating Antibody Glycosylation Using Traditional and PAT Methods
Khurshid, M., Bhebe, P., Zhang, L., Wang, T., Wu, R., Huang, J. C. J.

09:00 AM

(367f) Model Predictive in Vitro Dissolution Testing for Real-Time Release in Pharmaceutical End-to-End Integrated Continuous Manufacturing: An Equivalence Study
Su, Q., Hermant, P., Casati, F., Wu, W., Dubey, A., Botros, L. L., Born, S., Takizawa, B., Mascia, S., Takizawa, B.